Skip to main content
. 2023 Oct 9;37(6):2084–2092. doi: 10.1111/jvim.16897

TABLE 1.

Modified clinical activity index (MCAI) scoring system used as the primary endpoint for evaluating the clinical response to a daily IV administration of fuzapladib or placebo for 3 consecutive days to dogs with acute pancreatitis (AP).

Variable Score Description
Activity 0 Normal (as usual)
1 Slightly decreased (stands less than usual)
2 Moderately decreased (is reluctant to stand)
3 Severely decreased (cannot stand up)
Appetite a 0 Normal (ate more than ¾ of food offered)
1 Slightly decreased (ate about ½ of food offered)
2 Moderately decreased (ate about ¼ of food offered)
3 Severely decreased (did not eat or not much of the food offered)
Vomiting 0 None
1 1‐2 times/day
2 3‐4 times/day
3 ≥ 5 times/day
Cranial abdominal pain 0 None (no signs of pain)
1 Mild (abdominal wall resistance or other signs of pain are elicited upon palpation of abdomen; moves slowly or is less responsive)
2 Moderate (resists palpation; is reluctant to move when encouraged; does not lie on its side)
3 Severe (persistent vocalization, howling and/or insomnia)
Dehydration 0 None (<5%, no signs of dehydration)
1 Mild (5%, slight loss of skin elasticity)
2 Moderate (6%‐8%, increased skin turgor, slightly delayed capillary refill time, dry mucous membranes, sunken eyes)
3 Severe (≥10%, severely decreased skin turgor, delayed capillary refill time, deeply sunken eyes, severely dry mucous membranes)
Fecal consistency 0 Normal (well formed)
1 Soft (slightly watery and poorly formed)
2 Moderate (no form or runny)
3 Watery (watery with no solids and pale)
Blood in feces 0 Absent
1 Present

Abbreviations: AP, acute pancreatitis; MCAI, modified clinical activity index.

a

Voluntary food intake.